PFE

Pfizer Inc

$24.32 +0.44 (+1.84%) At close · Jul 2

Market Cap

$138.61B

5,699,444,169

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date	Headline
2026-06-24	Pfizer Declares Third-Quarter 2026 Dividend
2026-06-24	FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
2026-06-23	Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts
2026-06-22	Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
2026-06-18	Pfizer Announces Chief Financial Officer Transition
2026-06-08	U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
2026-06-06	Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide
2026-06-01	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
2026-05-31	Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
2026-05-30	TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
2026-05-29	Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer
2026-05-28	Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
2026-05-27	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
2026-05-20	Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

Past events

Date	Event	Type
2026-06-08	Goldman Sachs 47th Annual Global Healthcare Conference	Conference
2026-06-06	Pfizer Pflash Live from ADA: A Spotlight on Obesity	Event
2026-06-03	Jefferies Global Healthcare Conference	Conference
2026-05-05	Pfizer Quarterly Corporate Performance - First Quarter 2026	Event
2026-04-23	2026 Pfizer Annual Meeting of Shareholders	Shareholder meeting
2026-03-02	TD Cowen 46th Annual Health Care Conference	Conference
2026-02-03	Pfizer Quarterly Corporate Performance - Fourth Quarter 2025	Event
2026-01-12	44th Annual J.P. Morgan Healthcare Conference	Conference
2025-12-16	Pfizer Analyst and Investor Call to Review Pfizer Full-Year 2026 Financial Guidance	Event
2025-11-19	Jefferies London Healthcare Conference	Conference
2025-11-10	Pfizer Pflash: A Spotlight on the PF’4404 (SSGJ-707 / PF-08634404) Clinical Development Strategy	Event
2025-11-04	Pfizer Quarterly Corporate Performance - Third Quarter 2025	Event
2025-09-22	Pfizer Analyst and Investor Call to Discuss Proposed Acquisition of Metsera	Event
2025-08-05	Pfizer Quarterly Corporate Performance - Second Quarter 2025	Event
2025-07-25	Pfizer Pflash: A Spotlight on the PD-1 x VEGF Bispecific Antibody	Event
2025-06-12	Pfizer Pflash: A Spotlight on Pfizer's Breast Cancer Portfolio	Event
2025-06-09	Goldman Sachs 46th Annual Global Healthcare Conference	Conference
2025-04-29	Pfizer Quarterly Corporate Performance - First Quarter 2025	Event
2025-04-24	Annual Meeting of Shareholders	Shareholder meeting
2025-03-28	Pfizer Pflash: A Spotlight on IRA Part D Redesign and its Impact in 2025	Event
2025-03-03	TD Cowen 45th Annual Health Care Conference	Conference
2025-02-27	Pfizer Pflash: A Spotlight on Antibody-Drug Conjugates (ADCs)	Event
2025-02-04	Pfizer Quarterly Corporate Performance - Fourth Quarter 2024	Event
2025-01-13	43rd Annual J.P. Morgan Healthcare Conference	Conference
2024-12-18	Pfizer Pflash: A Spotlight on Clostridioides difficile (C. diff) Vaccine Development	Event

Source: https://investors.pfizer.com/overview/default.aspx

Key facts CIK 78003 CUSIP 717081103 13F (30d) 112 filings 31 filers Visit website Investor relations